| Copyright © King's Printer, Victoria, British Columbia, Canada | Licence Disclaimer |
| B.C. Reg. 9/98 O.C. 35/98 | Deposited January 9, 1998 |
[Last amended July 2, 2024 by B.C. Reg. 174/2024 and includes amendments by B.C. Reg. 15/2024]
1 (1) The drug schedules are printed in an alphabetical format to simplify the process of locating each individual drug entry and determining its status in British Columbia.
(2) Each entry is preceded by a code noted as 1, 1A, 2 or 3, in which
| 1 | = | Schedule I | |
| 1A | = | Schedule IA | |
| 2 | = | Schedule II | |
| 3 | = | Schedule III. |
[am. B.C. Reg. 151/2023, s. 1.]
2 (1) Drugs listed in Schedules I, IA, II and III must be sold from licensed pharmacies.
(2) Unscheduled drugs may be sold from non-pharmacy outlets.
(3) The various schedules are differentiated as follows:
Schedule I (Prescription): Schedule I drugs require a prescription for sale and are provided to the public by a pharmacist following the diagnosis and professional intervention of a practitioner. The sale is controlled in a regulated environment as defined by provincial pharmacy legislation. Entries followed by a "V" superscript may be sold without having received a prescription if
(a) the drug is in a form not suitable for human use, or
(b) the main panel of the manufacturer's inner label and the manufacturer's outer label carry, in both official languages, the statement "For Veterinary Use Only" or "For Agricultural Use Only" immediately following or preceding the brand name, proper name or common name, in type size not less than one-half as large as the largest type on the label, and the product is sold in the original manufacturer's container.
Schedule IA (Triplicate/Duplicate Prescription Program): Drugs which may be sold by a pharmacist to a practitioner or on the prescription of a practitioner in accordance with the bylaws to the Pharmacy Operations and Drug Scheduling Act.
Schedule II (Professional Service Area): Drugs which may be sold by a pharmacist on a non-prescription basis and which must be retained within the Professional Service Area of the pharmacy where there is no public access and no opportunity for patient self-selection.
Schedule III (Professional Products Area): Drugs which may be sold by a pharmacist to any person from the self-selection Professional Products Area of a licensed pharmacy.
Unscheduled (Non-pharmacy Sale): Drugs which may be sold by a non-pharmacist to any person.
[am. B.C. Regs. 312/2001; 210/2002; 292/2021, s. 1; 151/2023, s. 2.]
[am. B.C. Regs. 9/98; 141/98; 418/98; 247/99; 31/2000; 355/2000; 377/2000; 378/2000; 132/2001; 211/2001; 312/2001; 21/2002; 210/2002; 232/2002; 233/2002; 288/2002; 19/2003; 303/2003; 142/2006; 169/2006; 137/2007; 200/2008; 45/2009; 46/2009; 286/2009; 2/2011; 64/2011; 189/2011; 190/2011; 192/2012; 180/2015; 181/2015; 83/2016; 160/2016; 230/2016; 279/2016; 6/2017, s. (b); 137/2018; 261/2018; 9/2019; 135/2019; 1/2020; 292/2021, s. 2; 106/2022; 227/2022; 102/2023; 151/2023, s. 3; 236/2023; 15/2024; 174/2024.]
| 1 | Abacavir and its salts |
| 1 | Abatacept |
| 1 | Abciximab |
| 1 | Acamprosate and its salts |
| 1 | Acarbose and its derivatives |
| 1 | Acebutolol and its salts |
| 1 | Acepromazine and its saltsV |
| 1 | Acetaminophen, when recommended for administration by intravenous injection |
| 3 | Acetaminophen (in sustained-release formulations containing greater than 650 mg per unit or in package sizes greater than 50 units) |
| 3 | Acetaminophen and ibuprofen, when sold in oral, fixed-dose combinations, in package sizes containing 20 000 mg or less of acetaminophen and 6 000 mg or less of ibuprofen |
| 2 | Acetaminophen and ibuprofen, when sold in oral, fixed-dose combinations, in package sizes containing either more than 20 000 mg of acetaminophen or more than 6 000 mg of ibuprofen |
| 1 | AcetanilideV |
| 2 | Acetarsol |
| 1 | Acetazolamide |
| 1 | Acetohexamide |
| 1 | Acetylcarbromal |
| 1 | Acetylcholine chloride |
| 2 | Acetylcysteine in injectable form |
| 1 | Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage unit in containers with more than 24 dosage units per container) |
| 2 | Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage unit in child-resistant containers with 24 or less dosage units per container or rectal preparations containing 150 mg or less per dosage unit) |
| 3 | Acetylsalicylic acid and its salts (in products intended for oral use by adults in strengths of 81 mg per dosage unit and 650 mg or greater per dosage unit and in rectal preparations containing more than 150 mg per dosage unit) |
| 1 | Acitretin and its salts and derivatives |
| 1 | Aconiazide and its salts |
| 1 | Acyclovir and its salts |
| 1 | Adalimumab |
| 1 | Adapalene and its salts and derivatives |
| 1 | Adefovir and its salts and derivatives |
| 1 | Adenosine or its salts when sold or recommended for administration by intravenous injection |
| 2 | Adiphene and its salts for parenteral use |
| 1 | Adrenocortical hormones and their salts and derivativesV, including but not limited to betamethasone dipropionate, betamethasone phosphate, betamethasone sodium, betamethasone valerate, budesonide, ciclesonide, clobetasone, cortisone, dexamethasone acetate, dexamethasone phosphate, dexamethasone sodium, difluprednate, fludrocortisone acetate, flunisolide, fluticasone furoate, fluticasone propionate, hydrocortisone aceponate, hydrocortisone acetate, hydrocortisone sodium, methylprednisolone acetate, methylprednisolone, methylprednisolone sodium, methylprednisolone succinate, mometasone furoate, prednisolone acetate, prednisolone phosphate, prednisolone sodium, prednisone, triamcinolone acetonide, triamcinolone hexacetonide (except (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin, (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other non-prescription medicinal ingredient that provides 1% or less hydrocortisone in preparations for topical use on the skin, (c) clobetasone butyrate, when sold in a concentration of 0.05% in cream preparations for topical use on the skin, (d) fluticasone propionate, when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per metered spray for individuals 18 years of age and older), (e) mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per spray for those 12 years of age and older, and (f) triamcinolone acetonide in a nasal spray that delivers 55 mcg per spray for adults and children 12 years of age and older |
| 1 | Agalsidase alfa |
| 1 | Alatrofloxacin and its salts and derivatives |
| 1 | Aldesleukin |
| 1 | Alefacept |
| 1 | Alemtuzumab |
| 1 | Alendronic acid and its salts |
| 1 | Alfacalcidol |
| 1A | Alfentanil |
| 1 | Alfuzosin and its salts |
| 1 | Aliskiren and its salts |
| 1 | Alkyl nitrites |
| 1 | Allergy serums |
| 2 | Allethrins |
| 1 | Allopurinol |
| 1 | Allylisopropylacetylurea |
| 1 | Almotriptan and its salts |
| 1 | Alpha-chloralose |
| 1 | Alphadolone and its salts |
| 1 | Alpha-hydroxy acids, including but not limited to citric acid, glycolic acid, lactic acid, malic acid, mandelic acid, ammonium glycolate, glycolic acid + ammonium glycolate, alpha-hydroxyethanoic acid + ammonium alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid, alpha-hydroxycaprylic acid, hydroxycaprylic acid, mixed fruit acid, triple fruit acid, tri-alpha hydroxy fruit acids, alpha-hydroxy and botanical complex, l-alpha hydroxy acid, glycomer in cross-linked fatty acids alpha nutrium, when sold in topical formulations containing alpha-hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.0, except when sold to be applied to warts, corns or calluses |
| 1 | Alphaxalone |
| 1 | Alprazolam |
| 1 | Alteplase and its salts and derivatives |
| 1 | Altrenogest |
| 1 | Altretamine |
| 1 | Alverine and its salts in injectable form |
| 1 | Amantadine and its salts |
| 1 | Ambenonium chloride |
| 1 | Ambrisentan |
| 1 | Amifostine and its salts |
| 1 | Amikacin and its salts and derivatives |
| 1 | Amiloride and its salts |
| 1 | 4-Amino-pteroyl aspartic acid and its salts |
| 1 | Amino acid solutions in injectable form |
| 1 | Aminocaproic acid |
| 1 | Aminoglutethimide |
| 1 | Aminolevulinic acid and its salts and derivatives |
| 1 | Aminophylline |
| 1 | Aminopromazine [proquamezine] and its salts |
| 1 | Aminopterin and its salts |
| 1 | Aminopyrine and its derivativesV |
| 1 | 4-Aminosalicylic acid and its salts |
| 1 | 5-Aminosalicylic acid |
| 1 | Amiodarone and its salts |
| 1 | Amitraz |
| 1 | Amitriptyline and its salts |
| 1 | Amlexanox and its salts and derivatives |
| 1 | Amlodipine and its salts |
| 1 | Ammonium bromide |
| 1 | Amobarbital |
| 1 | Amoxapine |
| 1 | Amoxicillin and its salts and derivatives |
| 1 | Amphetamine |
| 1 | Amphotericin B and its salts and derivatives |
| 1 | Ampicillin and its salts and derivatives |
| 1 | Amprenavir and its salts and derivatives |
| 1 | Amprolium and its saltsV |
| 1 | Amrinone and its salts |
| 1 | Amsacrine and its salts |
| 2 | Amylocaine and its salts (for ophthalmic or parenteral use) |
| 3 | Amylocaine and its salts (preparations for topical use on mucous membranes except lozenges) |
| 1 | Anagrelide and its salts |
| 1 | Anakinra and its salts and derivatives |
| 1 | Anastrozole |
| 1 | Ancestim |
| 3 | Anetholtrithione |
| 1 | Anidulafungin |
| 1A | Anileridine |
| 2 | Anisotropine and its salts |
| 3 | Antazoline and its salts |
| 2 | Anthralin |
| 2 | Antihemophilic factor, human |
| 1 | Antipyrine (except preparations for topical use)V |
| 2 | Antipyrine (except otic preparations) |
| 3 | Antipyrine (for otic use) |
| 1 | Anti-thymocyte globulin |
| 1 | Apomorphine and its salts |
| 1 | Apraclonidine and its salts |
| 1 | Apramycin and its saltsV |
| 1 | Aprepitant and its derivatives |
| 1 | Aprotinin |
| 1 | Argatroban and its salts and derivatives |
| 1 | L-Asparaginase |
| 1 | Astemizole and its salts |
| 1 | Atazanavir and its salts |
| 1 | Atenolol and its salts |
| 1 | Atipamezole and its salts |
| 1 | Atomoxetine and its salts |
| 1 | Atorvastatin and its salts |
| 1 | Atovaquone |
| 1 | Atracurium besilate |
| 1 | Atropine and its salts (in ophthalmic or parenteral preparations) |
| 1 | Auranofin |
| 1 | Aurothioglucose |
| 1 | Azacyclonol and its salts |
| 1 | Azaribine |
| 1 | Azathioprine and its salts |
| 1 | Azatadine and its salts |
| 1 | Azelaic acid |
| 1 | Azelastine and its salts |
| 1 | Azithromycin and its salts and derivativesV |
| 1 | Azlocillin and its salts and derivatives |
| 1 | Aztreonam and its salts |
| 1 | Bacitracin and its salts and derivatives (for parenteral use) |
| 3 | Bacitracin and its salts and derivatives (for ophthalmic use) |
| 1 | Baclofen and its salts |
| 1 | Bambuterol and its salts |
| 1 | Basiliximab |
| 1 | Becaplermin |
| 1 | Bemegride |
| 1 | Benactyzine and its salts |
| 1 | Benazepril and its salts and derivatives |
| 1 | Bendazac and its salts |
| 1 | Benoxaprofen and its salts |
| 2 | Benoxinate hydrochloride (oxybuprocaine) (for ophthalmic or parenteral use) |
| 1 | Benserazide and its salts |
| 2 | Bentiromide |
| 2 | Benzalkonium and its salts (liquid preparations in concentrations of more than 2%) |
| 1 | Benzathine penicillin and its salts and derivatives |
| 2 | Benzethonium chloride (liquid preparations in concentrations of more than 1%) |
| 2 | Benzocaine and its salts in injectable form |
| 3 | Benzonatate |
| 1 | Benzoyl peroxide (in concentrations greater than 5% or when sold in combination with another medicinal ingredient) |
| 1 | Benzphetamine |
| 1 | Benztropine and its salts |
| 1 | Benzydamine and its salts |
| 1 | Bepotastine and its salts or derivatives |
| 1 | Beractant |
| 1 | Besifloxacin and its salts |
| 1 | Betahistine and its salts |
| 1 | Betaine and its salts when sold or recommended for the treatment of homocystinuriaV |
| 1 | Betaxolol and its salts |
| 1 | Bethanechol chloride |
| 1 | Bethanidine and its salts |
| 1 | Bevacizumab |
| 1 | Bezafibrate and its salts and derivatives |
| 1 | Bicalutamide |
| 1 | Bilastine or its salts or derivatives |
| 1 | Bimatoprost and its derivatives |
| 1 | Biperiden and its salts |
| 3 | Bisacodyl and its salts (except when sold in strengths of 5 mg or less per oral dosage unit in package sizes containing no more than 105 mg of bisacodyl and except when sold in strengths of 10 mg or less per rectal dosage unit/suppository in package sizes containing no more than 50 mg of bisacodyl) |
| 1 | Bishydroxycoumarin and its salts and derivatives |
| 1 | Bisoprolol and its salts |
| 1 | Bitolterol and its salts |
| 1 | Bivalirudin |
| 1 | Bleomycin |
| 1 | Bortezomib |
| 1 | Bosentan and its salts and derivatives |
| 1 | Botulinum Toxin Type A |
| 1 | Botulinum Toxin Type B |
| 1 | Bretylium tosylate |
| 1 | Brimonidine or its salts (except when sold as brimonidine tartrate ophthalmic solution in concentrations up to and including 0.025%, used for the relief of redness of the eye due to minor eye irritations caused by environmental allergies, dryness and fatigue for adults of 18 years and older) |
| 1 | Bromal |
| 1 | Bromal hydrate |
| 1 | Bromazepam and its salts |
| 1 | Brometone |
| 1 | Bromisoval |
| 1 | Bromocriptine and its salts |
| 1 | Bromoform |
| 3 | Brompheniramine and its salts as a single entity for the treatment of allergies |
| 2 | Buclizine |
| 2 | Bufexamac |
| 1 | Bumetanide and its salts and derivatives |
| 2 | Bupivacaine and its salts (for parenteral or ophthalmic use) |
| 3 | Bupivacaine and its salts (for topical use on mucous membranes except lozenges) |
| 1A | Buprenorphine |
| 1 | Bupropion and its salts |
| 1 | Buserelin and its salts |
| 1 | Buspirone and its salts |
| 1 | Busulfan |
| 2 | Butacaine and its salts (for ophthalmic or parenteral use) |
| 1A | Butalbital |
| 1 | Butaperazine and its salts |
| 1 | Butoconazole and its salts |
| 1A | Butorphanol |
| 1 | Butyl chloral hydrate |
| 1 | Cabergoline and its salts |
| 1 | Calcipotriol |
| 1 | Calcitonin |
| 1 | Calcitriol |
| 1 | Calcium bromide |
| 1 | Calcium bromolactobionate |
| 1 | Calcium carbimide |
| 1 | Calcium chloride in injectable form for parenteral use |
| 2 | Calcium disodium edetate |
| 1 | Calcium gluconate in injectable form for parenteral nutrition |
| 3 | Calcium polycarbophil |
| 1 | Calcium salts when sold for the treatment of hyperphosphatemiaV |
| 1 | Candesartan and its salts and derivatives |
| 1 | Candicidin and its salts and derivatives |
| 1 | Capecitabine and its salts and derivatives |
| 1 | Capreomycin and its salts and derivatives |
| 1 | Captodiamine and its salts |
| 1 | Captopril and its salts |
| 1 | Carbachol |
| 1 | Carbamazepine |
| 1 | Carbenicillin and its salts and derivatives |
| 1 | Carbenoxolone and its salts |
| 1 | Carbetocin and its salts |
| 1 | Carbidopa and its salts |
| 1 | Carbimazole |
| 3 | Carbinoxamine and its salts |
| 1 | Carbocisteine |
| 1 | Carbomycin and its salts and derivatives |
| 1 | Carboplatin |
| 1 | Carbromal |
| 1 | Carisoprodol |
| 1 | Carmustine |
| 1 | Carphenazine and its salts |
| 1 | Carprofen and its salts and derivatives |
| 1 | Carvedilol and its salts |
| 1 | Caspofungin and its salts and derivatives |
| 1 | Cefdinir and its salts and derivatives |
| 1 | Cefepine and its salts and derivatives |
| 1 | Cefonicide and its salts |
| 1 | Cefoperazone and its salts and derivatives |
| 1 | Cefprozil and its salts and derivatives |
| 1 | Ceftibuten and its salts and derivatives |
| 1 | Celecoxib and its salts |
| 1 | Cephalosporin C and its salts and derivatives |
| 3 | Cerapon |
| 1 | Cerivastatin and its salts |
| 1 | Cetirizine and its salts (when sold in concentrations greater than 8.5 mg cetirizine base per dosage unit) |
| 3 | Cetirizine and its salts (in concentrations of 10 mg equivalent to 8.5 mg or less of cetirizine base per dosage unit) in products marketed for pediatric use (under 12 years of age) |
| 1 | Cetrorelix and its salts |
| 1 | Cetuximab |
| 2 | Charcoal (activated) when sold as a poisoning antidote |
| 3 | Chlophedianol and its salts |
| 1 | Chloral |
| 1 | Chloral hydrate (oral) |
| 1 | Chloralformamide |
| 1 | Chloralimide |
| 1 | Chlorambucil and its salts and derivatives |
| 1 | Chloramphenicol and its salts and derivatives |
| 1 | Chlorcyclizine and its salts (except in preparations for external use only) |
| 1 | Chlordiazepoxide and its salts |
| 1 | Chlorhexidine and its salts (when used as a topical oral preparation)V |
| 1 | Chlorisondamine and its salts |
| 1 | Chlormezanone |
| 2 | Chloroprocaine and its salts (for parenteral or ophthalmic use) |
| 3 | Chloroprocaine and its salts (topical on mucous membranes except lozenges) |
| 1 | Chloroquine and its salts |
| 1 | Chlorothiazide and its salts and derivativesV |
| 1 | Chlorpromazine and its saltsV |
| 1 | Chlorpropamide |
| 1 | Chlorprothixene and its salts |
| 3 | Chlorzoxazone and its salts |
| 2 | Cholecystokinin |
| 1 | Cholestyramine resinV |
| 2 | Choline bitartrate in injectable form |
| 1 | Choline salicylate (when sold in combination with magnesium salicylate) |
| 1 | Choline theophyllinate |
| 1 | Choriogonadotropin alfa |
| 1 | Chromium chloride (chromic chloride) in injectable form for parenteral nutrition |
| 2 | Chymopapain in injectable form |
| 2 | Chymotrypsin in injectable form |
| 1 | Ciclopirox and its salts |
| 1 | Cilastatin and its salts |
| 1 | Cilazapril and its salts and derivatives |
| 1 | Cimetidine or its salts (except when sold in concentrations of 200 mg or less per oral dosage unit and indicated for the treatment of heartburn) |
| 3 | Cimetidine or its salts, when sold in concentrations of 100 mg or less per oral dosage unit and indicated for the treatment of heartburn |
| 1 | Cinacalcet and its salts |
| 2 | Cinchocaine (dibucaine) and its salts (for ophthalmic or parenteral use) |
| 1 | Cinchophene and its salts |
| 1 | Cinoxacin |
| 1 | Ciprofloxacin and its salts |
| 1 | Cisapride and its salts |
| 1 | Cisatracurium besilate |
| 1 | Cisplatin |
| 1 | Citalopram and its salts |
| 1 | Cladribine and its salts |
| 1 | Clarithromycin and its salts and derivativesV |
| 3 | Clemastine and its salts |
| 1 | Clenbuterol and its salts |
| 2 | Clidinium and its salts |
| 1 | Clindamycin and its salts and derivatives |
| 1 | Clobazam and its salts |
| 2 | Clobetasone butyrate (when sold in a concentration of 0.05% clobetasone butyrate in cream preparations for topical use on the skin) |
| 1 | Clodronic acid and its salts |
| 1 | Clofibrate |
| 1 | Clomiphene and its salts |
| 1 | Clomipramine and its salts |
| 1 | Clonazepam and its salts |
| 1 | Clonidine and its salts |
| 1 | Clopidogrel and its salts |
| 1 | Cloprostenol and its salts and derivatives |
| 1 | Clorazepic acid and its salts |
| 1 | Clotrimazole and its salts (except preparations for topical or intra-vaginal use) |
| 3 | Clotrimazole and its salts (preparations for intra-vaginal use) |
| 1 | Cloxacillin and its salts and derivatives |
| 1 | Clozapine and its salts |
| 2 | Coal tar (in concentrations of more than 10%) |
| 1 | Codeine and its salts, except (a) when prescribed as a single entity, (b) when included in a preparation containing 60 mg or more per dosage unit, (c) when included in a liquid preparation containing 1.6 mg or more per mL, or (d) in preparations exempted from the Regulations to the Controlled Drugs and Substances Act (Canada) |
| 1A | Codeine and its salts when (a) prescribed as a single entity, (b) included in a preparation containing 60 mg or more per dosage unit, or (c) included in a liquid preparation containing 1.6 mg or more per mL |
| 2 | Codeine and its salts (in preparations exempted from the Regulations to the Controlled Drugs and Substances Act (Canada)) |
| 2 | Collagenase (as debriding agent) |
| 1 | Colchicine |
| 1 | Colestipol and its salts |
| 1 | Colfosceril and its derivatives |
| 1 | Colistin and its salt and derivatives |
| 1 | Copper chloride (cupric chloride) in injectable form for parenteral nutrition |
| 1 | Copper sulfate in injectable form for parenteral nutrition |
| 1 | CorticotrophinV |
| 1 | CosyntropinV |
| 1 | Cromoglycic acid and its salts (except sodium cromoglycate in concentrations of 2% or less, in solutions for ophthalmic or intranasal use) |
| 3 | Cromoglycic acid and its salts in solutions of sodium cromoglycate in concentrations of 2% or less, for ophthalmic or intranasal use |
| 2 | Crotamiton |
| 2 | Cyclandelate |
| 2 | Cyclazocine and its salts |
| 1 | CyclizineV |
| 1 | Cyclobenzaprine and its salts |
| 2 | Cyclomethacaine and its salts (for ophthalmic or parenteral use) |
| 2 | Cyclopentamine and its salts |
| 1 | Cyclopentolate and its salts (in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada) |
| 2 | Cyclopentolate and its salts (except for ophthalmic or parenteral use) |
| 1 | Cyclophosphamide |
| 1 | Cycloserine |
| 1 | Cyclosporine |
| 2 | Cyproheptadine and its salts |
| 1 | Cyproterone and its derivatives |
| 1 | Cytarabine and its salts |
| 1 | Dabigatran and its salts and derivatives |
| 1 | Dacarbazine |
| 1 | Daclizumab |
| 1 | Dactinomycin |
| 1 | Dalfopristin and its salts |
| 1 | Dalteparin and its salts |
| 1 | Danaparoid and its salts and derivatives |
| 1 | Danazol |
| 1 | Danofloxacin and its salts |
| 3 | Danthron |
| 1 | Dantrolene and its salts |
| 1 | Dapiprazole and its salts |
| 1 | Daptomycin |
| 1 | Darifenacin and its salts |
| 1 | Dasatanib |
| 1 | Daunorubicin and its salts |
| 1 | Debrisoquin and its salts |
| 1 | Deferasirox |
| 1 | Deferoxamine and its salts |
| 3 | Dehydrocholic acid and its salts |
| 1 | Delavirdine and its salts |
| 1 | Deoxycholic acid and its salts, when used in an injectable form |
| 1 | Deracoxib |
| 1 | Deserpidine and its alkaloids and salts |
| 1 | Desflurane |
| 1 | Desipramine and its salts |
| 3 | Desloratadine and its salts and preparations (in products marketed for paediatric use — under 12 years of age) |
| 1 | Desmopressin and its salts |
| 2 | Desoxyribonuclease [pancreatic dornase] |
| 1 | Detomidine and its salts |
| 3 | Dexbrompheniramine and its salts |
| 3 | Dexchlorpheniramine and its salts |
| 1 | Dexfenfluramine and its salts |
| 1 | Dexraoxane and its salts |
| 1 | Dextroamphetamine or its salts |
| 3 | Dextromethorphan and its salts (except in oral dosage forms in package sizes containing no more than 300 mg dextromethorphan base or 409.3 dextromethorphan hydrobromide) |
| 2 | Dextrose in injectable form, when used as a sclerosing agent |
| 1 | Dextrose injection in concentrated solutions for parenteral nutrition |
| 1A | Diacetylmorphine |
| 1 | Diazepam and its salts |
| 1 | Diazoxide and its salts |
| 1 | Dichloroacetic Acid |
| 1 | Diclofenac and its salts, including but not limited to diclofenac diethylamine, diclofenac sodium and diclofenac potassium, except when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less of diclofenac for not more than 7 days |
| 3 | Diclofenac diethylamine, for human use, when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days, (a) in concentrations greater than 1.16% and less than or equal to 2.32%, and (b) in package sizes containing greater than 2.6 g of diclofenac diethylamine |
| 1 | Dicloxacillin and its salts and derivatives |
| 2 | Dicyclomine and its salts (except topicals and lozenges) |
| 1 | Didanosine and its salts and derivatives |
| 1 | Diethylbromacetamide |
| 1 | Diethylcarbamazine and its salts |
| 1 | Diethylstilbestrol and its derivatives |
| 1 | Difloxacin and its salts and derivatives |
| 1 | Diflunisal and its salts |
| 1 | Digitalis lanata and its glycosides (Grecian foxglove) |
| 1 | Digitalis purpurea and its glycosides (Common foxglove) |
| 1 | Digoxin immune Fab (ovine) |
| 2 | Dihydroquinidine and its salts (except phenylbarbiturate) |
| 1 | Dihydrostreptomycin and its salts and derivativesV |
| 1 | Dihydrotachysterol |
| 1 | Diiodohydroxyquin (except in preparations for topical use on the skin) |
| 2 | Diiodohydroxyquin (for topical use) |
| 1 | Diltiazem and its salts |
| 2 | Dimenhydrinate and its salts (for parenteral use) |
| 3 | Dimenhydrinate and its salts (for oral or rectal use) |
| 1 | Dimercaprol |
| 3 | Dimethothiazine |
| 1 | Dimethyl sulfoxide, for veterinary use or when sold for the treatment of interstitial cystitis or scleroderma in humans |
| 3 | Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice |
| 1 | 2,4-Dinitrophenol and its salts and derivatives |
| 1 | Dinoprostone and its salts and derivatives |
| 2 | Diperodon and its salts (except for topical use) |
| 2 | Diphenhydramine and its salts and preparations (for parenteral use or for topical use in concentrations of greater than 2%) |
| 3 | Diphenhydramine and its salts and preparations (except for parenteral use or for topical use in concentrations of 2% or less when sold in containers of 300 mg or less of diphenhydramine hydrochloride) |
| 1 | Diphenidol and its salts |
| 1 | Diphenoxylate or its salts |
| 1 | Diphenylhydantoin (phenytoin) and its salts |
| 3 | Diphenylpyraline |
| 1 | Dipivefrin and its salts |
| 1 | Diprophylline and its salts |
| 1 | Dipyridamole |
| 1 | DirithromycinV |
| 1 | Disopyramide and its salts |
| 1 | Disulfiram |
| 2 | Dithranol (Anthralin) |
| 1 | Dobutamine and its salts |
| 1 | Docetaxel and its derivatives |
| 1 | Dolasetron and its salts |
| 1 | Domperidone |
| 1 | Donepezil and its salts |
| 1 | Dopamine and its salts, when sold for administration by injection |
| 1 | Dornase alfa |
| 1 | Dorzolamide and its salts |
| 1 | Doxacurium chloride |
| 1 | Doxapram |
| 1 | Doxazosin and its salts |
| 1 | Doxepin and its salts |
| 1 | Doxercalciferol and its derivatives |
| 1 | Doxorubicin and its salts |
| 1 | Doxycycline and its salts and derivatives (when sold for intramuscular administration in caged birds) |
| 1 | Doxylamine and its salts (when sold or recommended for use in the nausea or vomiting of pregnancy) |
| 3 | Doxylamine and its salts (except those sold for nausea and vomiting of pregnancy) |
| 1 | Droperidol and its salts |
| 1 | Drotrecogin |
| 1 | Duloxetine and its salts |
| 1 | Dutasteride |
| 2 | Dyclonine (except for topical use on mucous membranes) |
| 3 | Dyclonine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Econazole and its salts |
| 1 | Ecothiophate and its saltsV |
| 1 | Ectylurea and its salts |
| 1 | Eculizumab |
| 1 | Edrophonium chloride |
| 1 | Efalizumab |
| 1 | Efavirenz |
| 1 | Efinaconazole |
| 1 | Eflornithine and its salts and derivatives |
| 1 | Eletriptan and its salts |
| 1 | Embutramide |
| 1 | Emedastine and its salts |
| 1 | Emtricitabine |
| 1 | Emylcamate |
| 1 | Enalaprilat and its salts and derivatives |
| 1 | Enflurane |
| 1 | Enfuvirtide |
| 1 | Enoxaparin and its salts |
| 1 | Enrofloxacin |
| 1 | Entacapone |
| 1 | Entecavir |
| 1 | Ephedrine and its salts (in preparations containing more than 8 mg per unit dose or with a label recommending more than 8 mg per dose or 32 mg per day, or labelled or implied for use exceeding 7 days, or if indicated for other than nasal congestion) |
| 3 | Ephedrine and its salts in combination products (in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use for no more than 7 days, and indicated for nasal congestion) |
| 2 | Ephedrine and its salts in single entity products (in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use for no more than 7 days, and indicated for nasal congestion) |
| 1 | Epinephrine and its salts in injectable form, except in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens |
| 2 | Epinephrine and its salts (in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens) |
| 1 | Epinephrine or its salts, when sold as epinephrine topical solution for hemostasis at a concentration equal to or greater than 1 mg/ml (1:1000) |
| 1 | Epirubicine and its salts |
| 1 | Epoprostenol and its salts |
| 1 | Eprosartan and its salts and derivatives |
| 1 | Epsiprantel |
| 1 | Eptifibatide and its salts |
| 1 | Ergot alkaloids and their saltsV |
| 1 | Erlotinib and its salts |
| 1 | Ertapenem and its salts |
| 1 | Erythrityl tetranitrate |
| 1 | Erythromycin and its salts and derivativesV |
| 1 | Erythropoietin |
| 1 | Escitalopram and its salts |
| 1 | Esketamine |
| 1 | Esmolol and its salts |
| 1 | Esomeprazole or its salts for human use including but not limited to esomeprazole magnesium except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of esomeprazole |
| 3 | Esomeprazole or its salts for human use when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of esomeprazole |
| 1 | Esomeprazole or its salts for veterinary use |
| 1 | Estazolam and its salts |
| 1 | Estramustine and its salts |
| 1 | Etanercept |
| 1 | Ethacrynic acid |
| 1 | Ethambutol and its salts |
| 2 | Ethanolamine oleate |
| 1A | Ethchlorvynol |
| 1 | Ethinamate |
| 1 | Ethionamide and its salts |
| 2 | Ethoheptazine and its salts |
| 1 | Ethomoxane and its salts |
| 1 | Ethopropazine hydrochloride (profenamine and its salts) |
| 1 | Ethotoin and its salts |
| 2 | Ethyl Chloride (except in trace amounts) |
| 1 | Ethyl trichloramate |
| 1 | Ethylpapaverine and its salts |
| 1 | Etidronic acid and its salts |
| 1 | Etodolac and its salts and derivatives |
| 1 | Etoposide and its derivatives |
| 1 | Etravirine and its salts |
| 1 | Etretinate |
| 1 | Etymemazine and its salts |
| 1 | Exemestane |
| 1 | Ezetimibe |
| 1 | Famciclovir and its salts |
| 1 | Famotidine and its salts (except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn) |
| 3 | Famotidine and its salts (when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 600 mg of famotidine) |
| 1 | Felodipine and its salts |
| 1 | Fenfluramine and its salts |
| 1 | Fenofibrate |
| 1 | Fenoprofen and its salts |
| 1 | Fenoterol and its salts |
| 1A | Fentanyl |
| 3 | Fexofenadine hydrochloride (in products marketed for pediatric use — under 12 years of age) |
| 2 | Fibrin |
| 2 | Fibrinolysin |
| 1 | Filgrastim |
| 1 | Finasteride |
| 1 | Flavoxate and its salts |
| 1 | Flecainide and its salts |
| 1 | Fleroxacin and its salts and derivatives |
| 1 | Floctafenine |
| 1 | Florfenicol and its derivatives |
| 1 | Fluconazole (except when sold in a concentration of 150 mg per oral dosage unit as a single dose treatment and indicated for the treatment of vaginal candidiasis) |
| 3 | Fluconazole (when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis, in package sizes containing no more than 150 mg of fluconazole) |
| 1 | Flucytosine |
| 1 | Fludarabine and its salts and derivatives |
| 1 | Flumazenil |
| 1 | Flunarizine and its salts |
| 1 | Flunixin and its salts and derivatives |
| 1 | Fluoride and its salts (in solid oral dosage forms containing more than 1 mg of fluoride ion) |
| 1 | Fluorouracil and its derivatives |
| 1 | Fluoxetine and its salts |
| 1 | Flupentixol and its salts and derivatives |
| 1 | Fluphenazine and its salts |
| 1 | Fluprostenol and its salts and derivatives |
| 1 | Flurazepam and its salts |
| 1 | Flurbiprofen and its salts |
| 1 | Fluspirilene |
| 1 | Flutamide |
| 2 | Fluticasone propionate, when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per metered spray, for individuals 18 years of age and older and in package sizes containing more than 360 metered sprays |
| 3 | Fluticasone propionate, when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per metered spray, for individuals 18 years of age and older and in package sizes containing no more than 360 metered sprays |
| 1 | Fluvastatin and its salts and derivatives |
| 1 | Fluvoxamine and its salt |
| 1 | Folic acidV |
| 1 | Folic acid (in preparations containing more than 1.0 mg of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 mg of folic acid) |
| 1 | Follicle stimulating hormone |
| 1 | Fomepizole and its salts |
| 1 | Fondaparinux sodium |
| 1 | Formestane and its salts and derivatives |
| 1 | Formoterol and its salts |
| 1 | Foscarnet sodium |
| 1 | Fosfomycin and its salts |
| 1 | Fosinopril and its salts |
| 1 | Fosphenytoin and its salts |
| 3 | Fractar |
| 1 | Framycetin and its salts and derivativesV |
| 1 | Frovatriptan and its salts |
| 1 | Fulvestrant |
| 1 | Furaltadone and its saltsV |
| 1 | Furazolidone and its saltsV |
| 1 | FurosemideV |
| 1 | Fusidic acid and its salts |
| 1 | Gabapentin and its salts and derivatives |
| 1 | Galantamine and its salts and derivatives |
| 1 | Gallamine triethiodide |
| 1 | Gallium and its salts |
| 1 | Ganciclovir and its salts |
| 1 | Ganirelix and its salts and derivatives |
| 1 | Gatifloxacin and its salts and derivatives |
| 1 | Gefitinib |
| 1 | Gemcitabine and its salts |
| 1 | Gemfibrozil and its salts |
| 1 | Gemifloxacin and its salts |
| 1 | Gentamicin and its salts and derivatives |
| 2 | Gentian Violet |
| 1 | Glatiramer and its salts |
| 1 | Gliclazide |
| 1 | Glimepiride |
| 1 | Glipizide |
| 2 | Glucagon |
| 1 | Glyburide and its salts and derivatives |
| 3 | Glyceroargentinate |
| 2 | Glycopyrrolate or its salts (except glycopyrronium bromide, including but not limited to glycopyrrolate, when used orally or for inhalation) |
| 1 | Glycopyrronium bromide (including but not limited to glycopyrrolate, when used orally or for inhalation) |
| 1 | Gold and its salts and derivatives, when sold for administration by injection |
| 1 | Golimumab |
| 1 | Gonadorelin and its salts |
| 1 | Gonadotropin, chorionic (human) |
| 1 | Gonadotropin, serum (human) |
| 1 | Goserelin and its salts |
| 3 | Gramicidin and its salts and derivatives (for ophthalmic use) |
| 1 | Granisetron and its salts |
| 1 | Grepafloxacin and its salts and derivatives |
| 1 | Griseofulvin and its salts and derivativesV |
| 1 | Guanethidine and its salts |
| 1 | Halazepam and its salt |
| 1 | Halofantrine and its salts |
| 1 | HaloperidolV |
| 3 | Haloprogin |
| 1 | Halothane |
| 2 | Heparin and its salts in injectable form |
| 1 | Hetacillin and its salts and derivatives |
| 1 | Hetastarch and its derivatives |
| 1 | Hexachlorophene and its salts |
| 1 | Hexacyclonate sodium |
| 1 | Hexamethonium and its salts |
| 1 | Histrelin and its salts |
| 1 | Homatropine and its salts (for ophthalmic or parenteral use or in preparations for oral use containing more than 2 mg per dosage unit) |
| 2 | Homatropine and its salts (for oral use in concentrations of 2 mg or less per dosage unit) |
| 2 | Human insulin |
| 1 | Hyaluronic acid and its salts (when sold or recommended for administration by intra-articular injection to horses) |
| 1 | Hydralazine and its salts |
| 1A | Hydrocodone (dihydrocodeinone) |
| 1A | Hydromorphone (dihydromorphone) |
| 1 | Hydroquinone or its derivatives, when sold in a concentration greater than 2% in preparations for topical use on the skinV |
| 1 | Hydroxychloroquine and its salts |
| 1 | 4-Hydroxycoumarin and its derivatives (when sold or recommended as anticoagulants) |
| 2 | Hydroxyephedrine and its salts |
| 1 | Hydroxyurea |
| 1 | Hydroxyzine and its salts and derivatives |
| 2 | Hyoscine butylbromide (Butylscopolamine bromide), except when recommended for injectable use |
| 1 | Hyoscine butylbromide (when recommended for parenteral use) |
| 2 | Hyoscine (scopolamine) in injectable form |
| 1 | Ibandronic acid and its salts |
| 1 | Ibuprofen and its salts except when sold in (a) an oral dosage form that provides 400 mg or less per dosage unit, or (b) a modified-release oral dosage form that provides 600 mg or less per dosage unit |
| 3 | Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding 18 000 mg) |
| 3 | Ibuprofen and its salts when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit |
| 1 | Ibutilide and its salts and derivatives |
| 1 | Idarubicin and its salts |
| 1 | Idoxuridine |
| 1 | Ifosfamide |
| 1 | Imatinib and its salts |
| 1 | Imiglucerase |
| 1 | Imipenem and its salts and derivatives |
| 1 | Imipramine and its salts |
| 1 | Imiquimod and its salts |
| 1 | Indapamide and its salts |
| 1 | Indinavir and its salts |
| 1 | Indomethacin |
| 1 | Infliximab |
| 1 | Inhaled human insulin |
| 1 | Inosiplex |
| 2 | Insulin |
| 1 | Interferon |
| 2 | Iodinated glycerol |
| 2 | Iodochlorhydroxyquin (for topical use) |
| 1 | Iodochlorhydroxyquin (except in preparations for topical use on the skin) |
| 1 | Ipratropium and its salts |
| 1 | Iproniazid and its salts |
| 1 | Irbesartan and its salts |
| 1 | Irinotecan and its salts |
| 1 | Iron derivatives (for parenteral use)V |
| 1 | Isocarboxazid and its salts |
| 1 | Isoflurane |
| 1 | Isoniazid |
| 1 | Isopropamide and its salts |
| 3 | Isopropyl myristate in concentration of 50% (for use in the treatment of head lice) |
| 1 | Isoproterenol (Isoprenaline) and its salts |
| 1 | Isosorbide and its salts and derivatives |
| 1 | Isotretinoin and its salts |
| 1 | Isoxsuprine and its salts |
| 1 | Isradipine and its salts |
| 1 | Itraconazole and its salts |
| 1 | Ivermectin and its derivatives (for human use or for veterinary use when sold for intramuscular injection into horses or for administration to dogs and cats) |
| 1 | Kanamycin and its salts and derivativesV |
| 1 | Ketamine and its salts |
| 1 | Ketanserin and its salts |
| 1 | Ketazolam and its salts |
| 1 | Ketoconazole and its salts (except in preparations for topical use as a shampoo) |
| 1 | Ketoprofene and its salts |
| 1 | Ketorolac and its salts |
| 1 | Ketotifen and its salts |
| 1 | Labetalol and its salts |
| 1 | Lactic acid (when recommended for use by injection as a tissue sclerosing agent) |
| 3 | Lactulose |
| 1 | Lamivudine and its salts |
| 1 | Lamotrigine and its salts |
| 1 | Lanreotide and its salts |
| 1 | Lansoprazole and its salts |
| 1 | Lanthanum salts (when sold for the treatment of hyperphosphatemia) |
| 1 | Lapatinib and its salts |
| 1 | Laronidase |
| 1 | Latanoprost |
| 1 | Leflunomide and its salts |
| 1 | Lenalidomide |
| 1 | Letrozole |
| 1 | Leucovorin and its salts |
| 1 | Leuprolide and its salts |
| 1 | Levallorphane and its salts |
| 1 | Levamisole and its saltsV |
| 2 | Levargorphane and its salts |
| 1 | Levetiracetam |
| 1 | Levobunolol and its salts |
| 1 | Levocabastine and its salts and derivatives |
| 1 | Levocarnitine and its salts and derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency |
| 1 | Levodopa and its salts |
| 2 | Levonordefrine |
| 2 | Levonorgestrel (when sold in concentrations of 1.5 mg or less per oral dosage unit, except when labelled to be taken as a single dose of 1.5 mg and in package sizes containing no more than 1.5 mg levonorgestrel, packaged and labelled for emergency contraception) |
| 3 | Levonorgestrel (when sold in concentrations of 1.5 mg or less per oral dosage unit to be taken as a single dose of 1.5 mg, packaged and labelled for emergency contraception, in package sizes containing no more than 1.5 mg of levonorgestrel) |
| 1A | Levorphanol |
| 1 | Lidocaine (when in a preparation containing an equal amount of tetracaine and recommended for topical use on the skin, in concentrations of 7% or higher) |
| 2 | Lidocaine and its salts (for ophthalmic or parenteral use, or topical use on mucous membranes, except lozenges) |
| 3 | Lidocaine and its salts (for otic use) |
| 3 | Lidocaine and prilocaine, eutectic mixture |
| 1 | Lincomycin and its salts and derivativesV |
| 2 | Lindane |
| 1 | Linezolid and its salts |
| 1 | Liothyronine and its saltsV |
| 1 | Lipid solutions in injectable form for parenteral nutrition |
| 1 | Lisdexamfetamine dimesylate |
| 1 | Lisinopril and its salts and derivatives |
| 1 | Lithium and its salts |
| 1 | Lodoxamide and its salts and derivatives |
| 1 | Lomefloxacin and its salts |
| 1 | Lomustine |
| 2 | Loperamide and its salts (in products marketed for pediatric use — under 12 years of age) |
| 1 | Lopinavir |
| 1 | Loracarbef and its salts and derivatives |
| 3 | Loratidine and its salts and preparations in products labelled for use in children aged 2 to 11 years, in package sizes containing greater than 140 mg of loratadine |
| 1 | Lorazepam and its salts |
| 1 | Losartan and its salts |
| 1 | Losoxantrone and its salts |
| 1 | Lovastatin |
| 1 | Loxapine and its salts |
| 1 | L-Tryptophan, when sold (a) for human use in oral dosage form at a concentration of more than 220 mg per dosage unit or per daily dose, as a single ingredient or in combination with other ingredients, or (b) for human or veterinary use as a single ingredient intended for any route of administration other than oral |
| 1 | Lumiracoxib |
| 1 | Lutropin alfa |
| 1 | Magnesium glutamate hydrobromide |
| 2 | Magnesium sulfate in injectable form |
| 1 | Magnesium sulfate in injectable form for parenteral nutrition |
| 1 | Manganese and its salts in injectable form for parenteral nutrition |
| 1 | Maprotiline and its salts |
| 1 | Maraviroc |
| 1 | Marbofloxacin and its salts and derivatives |
| 1 | Mazindol and its salts |
| 1 | MebendazoleV |
| 1 | Mecamylamine and its salts |
| 1 | Mechlorethamine and its salts |
| 1 | Mecillinam and its salts and derivatives |
| 1 | Meclizine and its saltsV (when sold in concentrations of more than 25 mg per dosage unit) |
| 3 | Meclizine and its salts (when sold in concentrations of 25 mg or less per dosage unit) |
| 1 | Meclofenamic acid and its salts |
| 1 | Medetomidine and its salts |
| 1 | Mefenamic acid and its salts |
| 1 | Mefloquine and its salts and derivatives |
| 1 | Megestrol and its salts |
| 1 | Melanoma therapeutic vaccine |
| 1 | Melarsomine and its salts when sold for the treatment of heartworm in dogs |
| 1 | Meloxicam and its salts and derivatives |
| 1 | Melphalan |
| 1 | Memantine and its salts |
| 1 | Menotropins (human) |
| 1 | Mepacrine and its salts |
| 1 | Mepazine and its salts |
| 1A | Meperidine (pethidine) |
| 1 | Mephenoxalone |
| 1 | Mephentermine and its salts |
| 2 | Mepivacaine and its salts (for ophthalmic or parenteral use) |
| 3 | Mepivacaine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Meprobamate |
| 1 | Mercaptopurine |
| 1 | Meropenem and its salts and derivatives |
| 1 | Mesna |
| 1 | Mesoridazine and its salts |
| 1 | Metaldehyde |
| 1 | Metaraminol bitartrate |
| 2 | Metathoheptazine and its salts |
| 1 | Metformin and its salts and derivatives |
| 1 | Methacholine and its salts |
| 1A | Methadone |
| 1 | Methamphetamine |
| 2 | Methantheline and its salts |
| 1A | Methaqualone |
| 1 | Methazolamide and its salts |
| 2 | Methdilazine and its salts |
| 2 | Metheptazine and its salts |
| 1 | Methicillin and its salts and derivatives |
| 1 | Methimazole |
| 1 | Methisazone |
| 3 | Methocarbamol (except for parenteral use) |
| 2 | Methocarbamol (for parenteral use) |
| 1 | Methoin (Mephenytoin) and its salts |
| 1 | Methotrexate and its salts |
| 1 | Methotrimeprazine and its salts |
| 1 | Methoxamine and its salts |
| 1 | Methoxsalene |
| 1 | Methoxy polyethylene glycol-epoetin beta |
| 1 | Methyldopa and its salts |
| 2 | Methylene Blue (for parenteral use) |
| 1 | Methylparafynol |
| 1 | Methylphenidate or its salts |
| 1 | Methyprylon |
| 1 | Methysergide and its salts and derivatives |
| 1 | Metoclopramide |
| 1 | Metolazone and its salts |
| 1 | Metomidate and its salts |
| 1 | Metopimazine and its salts |
| 1 | Metoprolol and its salts |
| 1 | Metronidazole |
| 1 | Metyrapone and its salts |
| 1 | Mexiletine and its salts |
| 1 | Mezlocillin and its salts and derivatives |
| 1 | Micafungin and its salts |
| 1 | Miconazole and its salts (except in preparations for topical or vaginal use) |
| 3 | Miconazole and its salts (for vaginal use) |
| 1 | Midazolam and its salts |
| 1 | Midodrine and its salts |
| 1 | Mifepristone or its derivatives |
| 1 | Miglustat |
| 1 | Milbemycin and its derivatives |
| 1 | Milrinone and its salts |
| 3 | Mineral tar (except shampoos with concentrations of less than 5%) |
| 1 | Minoxidil except when sold in preparations for topical use in concentrations of 5% or less |
| 1 | Mirtazapine and its salts |
| 1 | Mitomycin and its salts |
| 1 | Mitotane (o,p'-DDD) |
| 1 | Mitoxantrone and its salts |
| 1 | Mivacurium chloride |
| 1 | Modafinil and its salts |
| 1 | Molgramostim |
| 1 | Mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per spray for those 12 years of age and older |
| 2 | Monobenzone |
| 2 | Monoethanolamine oleate |
| 1 | Montelukast and its salts |
| 1A | Morphine |
| 1 | Moxidectin and its derivatives when sold for the prevention of heartworm in dogs |
| 1 | Moxifloxacin and its salts and derivatives |
| 1 | Mupirocin |
| 1 | Muromonab-CD3 |
| 1 | Mycophenolic acid and its salts and derivatives |
| 1 | Nabumetone |
| 1 | Nadolol and its salts |
| 1 | Nadroparin and its salts |
| 1 | Nafarelin and its salts and derivatives |
| 1 | Nafcillin and its salts and derivatives |
| 1 | Nalidixic acid |
| 1 | Nalmefene and its salts |
| 1 | Naloxone and its salts (except when used for opioid overdose emergencies) |
| 1 | Naltrexone and its salts and derivatives |
| 2 | Naphazoline and its salts (in nasal preparations for pediatric use) |
| 1 | Naproxen and its salts (except when sold as naproxen sodium 220 mg per oral dosage unit) |
| 3 | Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6 600 mg) |
| 1 | Naratriptan and its salts |
| 1 | Nateglinide and its salts and derivatives |
| 1 | Nedocromil and its salts |
| 1 | Nefazodone and its salts |
| 1 | Nelarabine |
| 1 | Nelfinavir and its salts |
| 1 | Neocinchophen and its salts |
| 1 | Neomycin and its salts and derivativesV |
| 1 | Neostigmine salts |
| 1 | Nepafenac |
| 1 | Netilmicin and its salts and derivatives |
| 1 | Nevirapine and its salts |
| 1 | Nialamide and its salts |
| 1 | NicarbazinV |
| 1 | Nicardipine and its salts |
| 1 | Nicotine and its salts for human use, except (a) in natural substances, (b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit, (c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day, (d) in a form to be administered into the oral cavity by means of a non-active device (one that operates on energy generated by the human body or by gravity) that delivers 4 mg or less of nicotine per dose for buccal absorption, or (e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit |
| 2 | Nicotine and its salts for human use in a form to be administered into the oral cavity by means of a non-active device (one that operates on energy generated by the human body or by gravity) that delivers 4 mg or less of nicotine per dose for buccal absorption |
| 1 | Nicotinic acid when sold in (a) a modified-release oral dosage form that provides 500 mg or more per dosage unit or per daily dose, or (b) an immediate-release oral dosage form that provides more than 500 mg per dosage unit or per daily dose |
| 1 | Nifedipine |
| 1 | Nikethamide |
| 1 | Nilotinib and its salts |
| 1 | Nilutamide |
| 1 | Nimodipine and its salts |
| 1 | Nitrazepam and its salts |
| 1 | Nitric oxide |
| 1 | Nitrofurantoin and its saltsV |
| 2 | Nitroglycerin (immediate-release sublingual dosage forms) |
| 1 | Nitroglycerin (except for immediate-release sublingual dosage forms) |
| 1 | Nitroscanate |
| 1 | Nizatadine and its salts |
| 1 | Nomifensine and its salts |
| 2 | Norepinephrine and its salts (levarterenol, noradrenaline) in injectable form |
| 1 | Norfloxacin |
| 1A | Normethadone |
| 1 | Nortriptyline and its salts |
| 1 | Novobiocin and its salts and derivativesV |
| 1 | Nylidrin and its salts |
| 1 | Nystatin and its salts and derivativesV (except preparations for topical use on the skin) |
| 3 | Nystatin and its salts and derivatives (in topical preparations for use on the skin) |
| 1 | Octatropine methylbromide |
| 1 | Octreotide |
| 1 | Ofloxacin and its salts |
| 1 | Olanzapine and its salts |
| 1 | Oleandomycin and its salts and derivativesV |
| 1 | Olmesartan and its salts and derivatives |
| 1 | Olopatadine and its salts |
| 1 | Olsalazine and its salts |
| 1 | Omalizumab |
| 1 | Omeprazole or its salts except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20mg in package sizes of no more than 280 mg of omeprazole |
| 2 | Omeprazole or its salts when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg in package sizes of no more than 280 mg of omeprazole |
| 1 | Ondansetron and its salts |
| 1 | Orbifloxacin and its salts and derivatives |
| 1 | Orciprenaline (Metaproterenol) and its salts |
| 1 | Orlistat |
| 1 | Ormetoprim and its salts |
| 1 | Ornidazole |
| 3 | Orphenadrine citrate |
| 1 | Orphenadrine hydrochloride |
| 1 | Oseltamivir and its salts |
| 1 | Oxacillin, and its salts and derivatives |
| 1 | Oxaliplatin |
| 1 | Oxanamide |
| 1 | Oxaprozin and its salts and derivatives |
| 1 | Oxazepam and its salts |
| 1 | Oxcarbazepine |
| 3 | Oxethazine |
| 1 | Oxolinic acid and its salts |
| 1 | Oxprenolol and its salts |
| 2 | Oxybuprocaine and its salts (benoxinate) (for ophthalmic or parenteral use) |
| 3 | Oxybuprocaine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Oxybutynin and its salts |
| 1A | Oxycodone |
| 2 | Oxymetazoline and its salts (in nasal preparations for pediatric use) |
| 1 | Oxyphenbutazone and its salts |
| 2 | Oxyquinoline |
| 1 | Oxytocin |
| 1 | Ozenoxacin and its salts |
| 1 | Paclitaxel and its derivatives |
| 1 | Palifermin |
| 1 | Paliperidone and its salts and derivatives |
| 1 | Palivizumab |
| 1 | Pamidronic acid and its salts |
| 1 | Pancreatic enzymes (in products for the treatment of established pancreatic insufficiency) |
| 1 | Pancreatic extracts when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency |
| 1 | Pancreatin (in products for the treatment of established pancreatic insufficiency) |
| 1 | Pancreatin when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency |
| 1 | Pancrelipase (in products for the treatment of established pancreatic insufficiency) |
| 1 | Pancrelipase when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency |
| 1 | Pancuronium and its salts |
| 1 | Panitumumab |
| 1 | Pantoprazole and its salts |
| 1 | Papaveretrine and its salts |
| 1 | Papaverine and its salts |
| 1 | Paraldehyde |
| 1 | Paramethadione |
| 1 | Pargyline and its salts |
| 1 | Paricalcitol |
| 1 | Paromomycin |
| 1 | Paroxetine and its salts |
| 2 | Paroxypropione |
| 1 | Pegaptanib and its salts |
| 1 | Pegfilgrastim |
| 1 | Pegvisomant |
| 1 | Pemetrexed and its salts |
| 1 | Penciclovir and its salts |
| 1 | Penicillamine |
| 1 | Pentaerythritol tetranitrate |
| 2 | Pentagastrin and its salts |
| 1 | Pentamidine and its salts |
| 1A | Pentazocine |
| 1 | Pentolinium tartrate |
| 1 | Pentosan polysulfate and its salts |
| 1 | Pentostatin and its salts |
| 1 | Pentoxifylline and its salts |
| 1 | Perflutren |
| 1 | Pergolide and its salts |
| 1 | Pericyazine and its salts |
| 1 | Perindopril and its salts |
| 2 | Permethrin |
| 1 | Perphenazine and its salts |
| 1 | Phacetoperane and its salts |
| 1 | Phenacemide |
| 1 | Phenacetin |
| 1 | Phenaglycodol |
| 1 | Phenazopyridine and its salts |
| 1 | Phendimetrazine and its salts |
| 1 | Phenelzine and its salts |
| 1 | Phenformin and its salts |
| 1 | Pheniprazine and its salts |
| 1 | Phenmetrazine and its salts |
| 1 | Phenobarbital or its salts |
| 2 | Phenoxybenzamine and its salts |
| 1 | Phenthoxate and its salts |
| 1 | Phentolamine and its salts |
| 1 | Phenylbutazone and its salts |
| 1 | Phenylephrine and its salts (in preparations for parenteral or ophthalmic use in concentrations greater than 2.5%) |
| 2 | Phenylephrine and its salts and preparations (in nasal preparations for pediatric use, in concentrations of 2.5% or less) |
| 1 | Phenylindanedione and its derivatives |
| 1 | Phenylpropanolamine and its salts and derivatives for veterinary use |
| 3 | Phenyltoloxamine and its salts |
| 1 | Physostigmine salicylate (except preparations for oral or topical use only)V |
| 1 | Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids, except (a) derivatives of cannabis as defined in subsection 2 (1) of the Cannabis Act (Canada) that are exempt from the application of that Act under the Industrial Hemp Regulations (Canada) and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, (b) anything referred to in Schedule 2 to the Cannabis Act (Canada) that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or (c) anything referred to in the Cannabis Exemption (Food and Drugs Act) Regulations (Canada) that is exempt from the application of the Food and Drugs Act (Canada) |
| 1 | Pilocarpine and its salts |
| 1 | Pimecrolimus |
| 1 | Pimobendan |
| 1 | Pimozide |
| 1 | Pinaverium bromide |
| 1 | Pindolol and its salts |
| 1 | Pioglitazone and its salts |
| 1 | Pipecuronium bromide |
| 1 | Piperacetazine and its salts |
| 2 | Piperazine and its salts |
| 1 | Piperilate and its salts |
| 2 | Piperonyl butoxide |
| 1 | Pipobroman |
| 1 | Pipotiazine and its salts |
| 1 | Pipradol and its salts |
| 1 | Pirbuterol and its salts |
| 1 | Pirenzepine and its salts |
| 1 | Pirlimycin and its salts |
| 1 | Piroxicam and its salts |
| 1 | Pizotyline and its salts |
| 1 | Podophyllum and the following extracts and active principles (when sold or recommended for topical use): podophyllum toxin and podophyllum resin |
| 2 | Polyacrylamide |
| 3 | Polymyxin B and its salts and derivatives (for ophthalmic use) |
| 1 | Polymyxin B and its salts and derivatives, (except for topical use or for local action in the oral cavity or nasal passages)V |
| 1 | Polysulfated glycosaminoglycan |
| 1 | Ponazuril |
| 1 | Poractant alfa |
| 1 | Porfimer and its salts |
| 1 | Posaconazole |
| 1 | Potassium bromide |
| 1 | Potassium citrate (when recommended for the treatment of renal tubular acidosis and kidney stones) |
| 1 | Potassium gluconate when sold or recommended for administration to cats |
| 1 | Potassium para-aminobenzoate (except in preparations for topical use on the skin) |
| 1 | Potassium salts (in preparations for injection) |
| 1 | Pralidoxime and its salts |
| 1 | Pramipexole and its salts |
| 2 | Pramoxine and its salts (for ophthalmic or parenteral use) |
| 3 | Pramoxine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Pravastatin and its salts |
| 1 | Prazepam and its salts |
| 1 | Praziquantel, except when sold for the treatment of the tapeworm Anoplocephala perfoliata in horses |
| 1 | Prazosin and its salts |
| 1 | Pregabalin and its salts and derivatives |
| 1 | Prenylamine and its salts |
| 2 | Prilocaine and its salts (for ophthalmic or parenteral use) |
| 3 | Prilocaine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Primaquine and its salts |
| 1 | PrimidoneV |
| 1 | Probenecid and its salts |
| 1 | Probucol |
| 1 | Procainamide and its salts |
| 2 | Procaine and its salts (for ophthalmic or parenteral use) |
| 3 | Procaine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Procarbazine and its salts |
| 1 | Procaterol and its salts |
| 1 | Prochlorperazine and its salts |
| 1 | Procyclidine and its salts |
| 1 | Prodilidine and its salts |
| 1 | Profenamine and its salts |
| 1 | Proguanil and its salts |
| 1 | Promazine and its saltsV |
| 2 | Promethazine and its salts (except for topical use) |
| 3 | Promethazine and its salts (for topical use) |
| 1 | Propafenone and its salts |
| 2 | Propantheline and its salts |
| 2 | Proparacaine and its salts (for ophthalmic or parenteral use) |
| 3 | Proparacaine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Propofol |
| 1A | Propoxyphene |
| 1 | Propranolol and its salts |
| 2 | Propylhexedrine |
| 1 | Proquamezine [aminopromazine] and its salts (for internal use) |
| 1 | Prostaglandins and their salts and derivatives |
| 2 | Protamine and its salts |
| 1 | Prothipendyl hydrochloride |
| 1 | Protirelin |
| 1 | Protriptyline and its salts |
| 3 | Pseudoephedrine and its salts and preparations in combination products |
| 2 | Pseudoephedrine and its salts and preparations in single entity products |
| 2 | Pyrantel and its salts |
| 1 | Pyrazinamide |
| 1 | Pyridostigmine bromide |
| 1 | Pyrimethamine and its salts |
| 2 | Pyrvinium and its salts |
| 1 | Quetiapine and its salts |
| 1 | Quinagolide and its salts |
| 1 | Quinapril and its salts and derivatives |
| 1 | Quinine or its salts or derivatives, except when sold in oral dosage form that provides 50 milligrams or less of quinine base per dosage unit or per daily dose |
| 1 | Quinupristin and its salts |
| 1 | Rabeprazole and its salts |
| 1 | Raloxifene and its salts |
| 1 | Raltegravir and its salts |
| 1 | Raltitrexed and its salts and derivatives |
| 1 | Ramipril and its salts and derivatives |
| 1 | Ranibizumab |
| 1 | Ranitidine and its salts (except when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn) |
| 3 | Ranitidine and its salts (when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 4 500 mg of ranitidine) |
| 1 | Rasburicase |
| 1 | Raubasine and its salts |
| 1 | Rauwolfia |
| 1 | Remoxipride and its salts |
| 1 | Repaglinide and its salts and derivatives |
| 1 | Rescinnamine and its salts |
| 1 | Reserpine and its saltsV |
| 1 | Resocortol and its derivatives |
| 1 | Retapamulin |
| 1 | Reviparin and its salts |
| 1 | Ribavirin |
| 1 | Rifabutin and its salts |
| 1 | Rifampin and its salts and derivatives |
| 1 | Riluzole and its salts |
| 1 | Risedronic acid and its salts |
| 1 | Risperidone and its salts |
| 1 | Ritodrine and its salts |
| 1 | Ritonavir |
| 1 | Rituximab |
| 1 | Rivaroxaban |
| 1 | Rivastigmine and its salts |
| 1 | Rizatriptan and its salts |
| 1 | Rocuronium bromide |
| 1 | Rofecoxib |
| 1 | Romifidine and its salts |
| 1 | Romiplostim |
| 1 | Ronidazole and its salts and derivativesV |
| 1 | Ropinirole and its salts |
| 2 | Rose Bengal |
| 1 | Rosiglitazone and its salts |
| 1 | Rosoxacin and its salts |
| 1 | Rosuvastatin and its salts |
| 1 | Rupatadine and its salts |
| 1 | Salbutamol and its salts |
| 1 | Salicylic acid (when sold in topical formulations containing salicylic acid at concentrations greater than 20% or with a pH less than 3.0, or both, except when sold to be applied to warts, corns or calluses) |
| 1 | Salmeterol and its salts |
| 1 | Salsalate and its salts and derivatives |
| 1 | Saquinavir and its salts and derivatives |
| 1 | Saralasin and its salts |
| 1 | Sargramostin |
| 1 | Secobarbital or its salts |
| 1 | Selegiline and its salts |
| 2 | Selenium (for parenteral use) |
| 1 | Selenium in injectable form for parenteral nutrition |
| 1 | Semaglutide |
| 1 | Sermorelin and its salts |
| 1 | Sertraline and its salts |
| 1 | Sevelamer hydrochloride |
| 1 | Sex hormonesV (the exemption from requiring a prescription if sold for veterinary use does not apply to those listed separately elsewhere in this schedule and those listed in the drug schedules associated with the Controlled Drugs and Substances Act (Canada), except those contained in an agricultural implant) |
| 1 | Sibutramine and its salts |
| 1 | Sildenafil and its salts |
| 1 | Simvastatin |
| 2 | Sincalide |
| 1 | Sirolimus and its derivatives |
| 1 | Sitagliptin and its salts |
| 1 | Sitaxentan and its salts |
| 2 | Sodium acetate in injectable form |
| 1 | Sodium acetate in injectable form for parenteral nutrition |
| 1 | Sodium aurothiomalate |
| 2 | Sodium biphosphate in injectable form |
| 1 | Sodium bromide |
| 1 | Sodium chloride in injectable form for parenteral nutrition |
| 2 | Sodium chloride, single ingredient solutions for injectable use in concentrations of more than 0.9% |
| 2 | Sodium citrate in injectable form |
| 1 | Sodium fluoride (in solid oral dosage forms containing more than one milligram of fluoride ion)V |
| 2 | Sodium iodide in injectable form, when used as a sclerosing agent |
| 1 | Sodium iodine in injectable form for parenteral nutrition |
| 1 | Sodium nitroprusside and its salts |
| 2 | Sodium phosphate in injectable form |
| 1 | Sodium phosphate in injectable form for parenteral nutrition |
| 2 | Sodium picosulphate for oral purgatives, 10 mg per pack (when found in preparations with magnesium oxide 3.5 g and citric acid 12 g) |
| 1 | Sodium polystyrene sulfonate |
| 2 | Sodium tetradecyl sulfate |
| 1 | Solifenacin and its salts |
| 1 | Somatostatin |
| 1 | Somatrem |
| 1 | Somatropin |
| 1 | Sotalol and its salts |
| 1 | Sotrovimab |
| 1 | Spectinomycin and its salts and derivativesV |
| 1 | Spiramycin and its salts and derivativesV |
| 1 | Spironolactone |
| 1 | Stavudine |
| 2 | Streptokinase (as a debriding agent) |
| 1 | Streptokinase/streptodornase |
| 1 | Streptomycin and its salts and derivativesV |
| 1 | Streptozocin |
| 2 | Strontium and its salts in injectable form (except strontium bromide) |
| 1 | Strontium bromide |
| 1 | Succinimide and its salts and derivatives (except those compounds used for decontaminating water) |
| 1 | Succinylcholine and its salts |
| 1 | Sucralfate |
| 1A | Sufentanil |
| 1 | Sulconazole and its salts |
| 1 | Sulfinpyrazone and its salts |
| 1 | Sulindac and its salts |
| 1 | Sulphonamides and their salts and derivativesV |
| 1 | Sulphones and their derivatives |
| 1 | Sumatriptan and its salts |
| 1 | Sunitinib and its salts |
| 1 | Suprofen and its salts |
| 2 | Sutilains |
| 1 | Suxamethonium chloride |
| 1 | Synthetic cannabinoid receptor type-1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers, as listed in the schedules associated with the Controlled Drugs and Substances Act (Canada) and the Narcotic Control Regulations (Canada) |
| 1 | Tacrolimus and its derivatives |
| 1 | Tadalafil and its salts |
| 1 | Tamoxifen and its salts |
| 1 | Tamsulosin and its salts |
| 1A | Tapentadol |
| 1 | Tazarotene |
| 1 | Tazobactam and its salts and derivatives |
| 1 | Teflubenzuron |
| 1 | Tegafur and its salts |
| 1 | Tegaserod and its salts |
| 1 | Telbivudine |
| 1 | Telithromycin and its salts and derivatives |
| 1 | Telmisartan and its salts and derivatives |
| 1 | Temazepam and its salts |
| 1 | Temozolomide and its salts |
| 1 | Tenecteplase and its salts and derivatives |
| 1 | Teniposide |
| 1 | Tenofovir and its salts and derivatives |
| 1 | Tenoxicam and its salts |
| 1 | Terazosin and its salts |
| 1 | Terbinafine and its salts |
| 1 | Terbutaline and its salts |
| 1 | Terconazole and its salts |
| 1 | Terfenadine and its salts |
| 1 | Teriparatide and its salts |
| 1 | Terlipressin and its salts |
| 1 | Tetrabenazine and its salts |
| 2 | Tetracaine and its salts (for ophthalmic or parenteral use) |
| 3 | Tetracaine and its salts (for topical use on mucous membranes, except lozenges) |
| 1 | Tetracaine (when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher) |
| 1 | Tetracycline and its salts and derivativesV (the exemption from requiring a prescription if sold for veterinary use does not apply if sold as doxycycline for intramuscular administration in caged birds) |
| 2 | Tetrahydrozoline (in nasal preparations for pediatric use) |
| 1 | Thalidomide |
| 1 | Theophylline and its salts |
| 1 | ThiabendazoleV |
| 1 | Thiethylperazine and its salts |
| 1 | Thiocarlide |
| 1 | Thioguanine |
| 1 | Thiopropazate and its salts |
| 1 | Thioproperazine and its salts |
| 1 | Thioridazine and its salts |
| 1 | Thiotepa |
| 1 | Thiothixene and its salts |
| 1 | Thiouracil and its derivatives |
| 2 | Thrombin |
| 2 | Thyroglobulin |
| 1 | ThyroidV |
| 2 | Thyrotropin |
| 1 | Thyrotropin alfa |
| 1 | Thyroxin and its salts |
| 1 | Tiaprofenic acid and its salts |
| 1 | Ticarcillin and its salts and derivatives |
| 1 | Ticlopidine and its salts |
| 1 | Tilmicosin |
| 1 | Tiludronic acid and its salts |
| 1 | Timolol and its salts |
| 1 | Tinidazole |
| 1 | Tinzaparin and its salts |
| 1 | Tioconazole and its salts (except in preparations for topical or intra-vaginal use in humans)V |
| 3 | Tioconazole and its salts (in preparations for intra-vaginal use) |
| 1 | Tiotropium bromide |
| 1 | Tipranavir and its salts |
| 1 | Tirofiban and its salts and derivatives |
| 1 | Tizanidine and its salts |
| 1 | Tobramycin and its salts and derivatives |
| 1 | Tocainide and its salts |
| 1 | Tolazamide |
| 1 | Tolazoline and its salts |
| 1 | Tolbutamide |
| 1 | Tolcapone |
| 1 | Tolfenamic acid and its salts and derivatives |
| 1 | Tolmetin and its salts |
| 1 | Tolterodine and its salts |
| 1 | Topiramate |
| 1 | Topotecan and its salts |
| 1 | Torasemide and its salts |
| 1 | Toremifene and its salts |
| 1 | Tramadol or its salts |
| 1 | Trandolaprilat and its salts and derivatives |
| 1 | Tranexamic acid |
| 1 | Tranylcypromine |
| 1 | Trastuzumab |
| 1 | Trazodone and its salts |
| 1 | Treosulfan |
| 1 | Treprostinil and its salts |
| 1 | Tretamine |
| 1 | Tretinoin and its salts and derivatives |
| 2 | Triamcinolone acetonide in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing more than 120 metered sprays |
| 3 | Triamcinolone acetonide in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing no more than 120 metered sprays |
| 1 | Triamterene and its salts |
| 1 | Triazolam and its salts |
| 1 | Tricaine and its salts |
| 3 | Triethanolamine oleate |
| 3 | Triethanolamine salicylate (in concentrations greater than 20%) |
| 1 | Trifarotene and its salts |
| 1 | Trifluoperazine and its salts |
| 1 | Triflupromazine and its salts |
| 1 | Trifluridine |
| 1 | Trihexyphenidyl and its salts |
| 1 | Triiodothyropropionic acid |
| 1 | Trilostane |
| 1 | Trimebutine and its salts |
| 1 | Trimeprazine and its saltsV |
| 1 | Trimethadione |
| 1 | Trimethaphan camsylate |
| 1 | Trimethoprim and its salts |
| 1 | Trimetrexate and its salts |
| 1 | Trimipramine and its salts |
| 1 | Trioxsalen |
| 3 | Tripelennamine and its salts |
| 3 | Triprolidine |
| 1 | Troglitazone |
| 1 | Tropicamide and its salts (in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada) |
| 1 | Trospium chloride |
| 1 | Trovafloxacin and its salts and derivatives |
| 1 | Tubocurarine and its salts |
| 1 | Tybamate |
| 1 | Tylosin and its salts and derivatives (when sold for the treatment of chronic colitis in dogs) |
| 1 | Tylosin and its salts and derivativesV (except when sold for the treatment of chronic colitis in dogs) |
| 3 | Tyrothricine |
| 1 | Ulipristal or its salts or derivatives (including but not limited to ulipristal acetate) |
| 1 | Unoprostone and its salts and derivatives |
| 1 | Uracil and its salts, when sold for the treatment of cancer |
| 2 | Urea (in topical preparations in concentrations of more than 25%) |
| 1 | Ursodeoxycholic acid and its salts |
| 1 | Ustekinumab |
| 1 | VaccinesV (except influenza, vaccines which are part of a routine immunization program, those requiring special enhanced public access due to disease outbreaks and cholera vaccine (oral, inactivated) when used for prophylaxis against traveler's diarrhea due to enterotoxigenic escherichia coli (ETEC)) |
| 2 | Vaccines (influenza, vaccines which are part of a routine immunization program, those requiring special enhanced public access due to disease outbreaks and cholera vaccine (oral, inactivated) when used for prophylaxis against traveler's diarrhea due to enterotoxigenic escherichia coli (ETEC)) |
| 1 | Valaciclovir and its salts |
| 1 | Valdecoxib and its salts |
| 1 | Valganciclovir and its salts and derivatives |
| 1 | Valproic acid and its salts |
| 1 | Valrubicin and its derivatives |
| 1 | Valsartan and its salts and derivatives |
| 1 | Vancomycin and its salts and derivatives |
| 1 | Vardenafil and its salts |
| 1 | Varenicline and its salts |
| 1 | Vasopressin and its salts |
| 1 | Vecuronium bromide |
| 1 | Vedaprofen and its salts and derivatives |
| 3 | Vegetable tar (except shampoos in concentrations of 5% or less) |
| 1 | Venlafoxine and its salts |
| 1 | Verapamil and its salts |
| 1 | Veratrum album and its alkaloids and their saltsV |
| 1 | Veratrum viride and its alkaloids and their saltsV |
| 1 | Verteporfin and its salts and derivatives |
| 1 | Vidarabine |
| 1 | Vigabatrin and its salts and derivatives |
| 1 | Vinblastine and its salts |
| 1 | Vincristine and its salts |
| 1 | Vindesine and its salts |
| 1 | Vinorelbine and its salts |
| 1 | Viomycin and its salts and derivatives |
| 1 | Virginiamycin and its salts and derivativesV |
| 1 | Vitamin AV |
| 1 | Vitamin A in oral dosage form containing more than 10 000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10 000 International Units of Vitamin A |
| 1 | Vitamin B12 with Intrinsic Factor Concentrate |
| 1 | Vitamin DV |
| 1 | Vitamin D in oral dosage form containing more than 62.5 mcg or 2 500 International Units of Vitamin D per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 62.5 mcg or 2 500 International Units of Vitamin D |
| 1 | Vitamin KV (except Vitamin K1 and Vitamin K2 sold (a) for external use in humans, or (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less) |
| 2 | Vitamins in injectable form, except those listed in Schedule I |
| 1 | Vitamins in injectable form for parenteral nutrition |
| 1 | Voriconazole |
| 1 | Vorinostat |
| 1 | Xanthinol nicotinate |
| 1 | Xylazine and its salts |
| 2 | Xylometazoline and its salts (in nasal preparations for pediatric use) |
| 1 | Yohimbine and its salts |
| 1 | Zafirlukast and its salts |
| 1 | Zalcitabine and its salts |
| 1 | Zanamivir and its salts and derivatives |
| 1 | Zeranol |
| 1 | Zidovudine |
| 1 | Zinc chloride in injectable form for parenteral nutrition |
| 1 | Zinc sulfate in injectable form for parenteral nutrition |
| 1 | Ziprasidone and its salts |
| 1 | Zoledronic acid and its salts and derivatives |
| 1 | Zomepirac and its salts |
| 1 | Zopiclone and its salts |
| 1 | Zuclopenthixol and its salts and derivatives |
| V | Prescription not required if sold for veterinary use, provided that the product is labelled by the manufacturer "for agricultural use only" or "for veterinary use only." |
[Provisions relevant to the enactment of this regulation: Pharmacy Operations and Drug Scheduling Act, S.B.C. 2003, c. 77, ss. 22 and 23 (4).]
Copyright © King's Printer, Victoria, British Columbia, Canada